Clinical Trial Update: B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of a B7.1/IL-2 leukemia cell vaccine for non-transplant acute myeloid leukemia and myelodysplastic syndromes; current status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• B7.1/IL-2 leukemia cell vaccine

Snippet

Sponsor: King's College London | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | Status: UNKNOWN